7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
pmid:25724681 | ||||
Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
pmid:25708645 | ||||
pmid:25694056 | ||||
Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
pmid:25684548 | ||||
Chung CP et al. | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. | 2015 | Int J Mol Sci | pmid:25679449 |
Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
pmid:25663522 | ||||
pmid:25660312 | ||||
Dumnicka P et al. | Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. | 2014 | Folia Med Cracov | pmid:25648306 |
HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
pmid:25645361 | ||||
pmid:25643339 | ||||
Shi W et al. | Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. | 2014 | Biosci Trends | pmid:25641178 |
Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
pmid:25634035 | ||||
pmid:25633918 | ||||
Dale MD et al. | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. | 2015 | Int J Mol Sci | pmid:25625518 |
pmid:25618600 | ||||
pmid:25618371 | ||||
pmid:25609157 | ||||
pmid:25607338 | ||||
Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
pmid:25589510 | ||||
pmid:25585925 | ||||
pmid:25585180 | ||||
Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
pmid:25572286 | ||||
pmid:25557611 | ||||
Ostrowska Z et al. | Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. | 2014 | Endokrynol Pol | pmid:25554611 |
pmid:25554597 | ||||
Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
pmid:25539196 | ||||
pmid:25536123 | ||||
pmid:25532817 | ||||
pmid:25518897 | ||||
Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
MacMillan AK et al. | Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. | 2014 | Int J Nanomedicine | pmid:25506216 |
pmid:25502845 | ||||
pmid:25499997 | ||||
pmid:25498379 | ||||
pmid:25494659 | ||||
Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
pmid:25486133 | ||||
pmid:25475457 | ||||
pmid:25475449 | ||||
Jiang Y et al. | Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. | 2014 | J Transl Med | pmid:25471933 |
pmid:25464125 | ||||
pmid:25461399 | ||||
Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
pmid:25460576 | ||||
pmid:25453890 | ||||
pmid:25450818 | ||||
pmid:25446507 | ||||
pmid:25446307 | ||||
pmid:25446166 | ||||
Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
pmid:25442456 | ||||
pmid:25438102 | ||||
pmid:25433965 | ||||
pmid:25415928 | ||||
pmid:25406873 | ||||
Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
Akiyama N et al. | Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. | 2014 | J. Exp. Med. | pmid:25385757 |
pmid:25383958 | ||||
Lv Y et al. | Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. | 2014 | BMC Musculoskelet Disord | pmid:25377946 |
D'Abramo A et al. | Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. | 2014 | Mediators Inflamm. | pmid:25374442 |
pmid:25373482 | ||||
Samir SM and Malek HA | Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. | 2014 | J. Physiol. Pharmacol. | pmid:25371528 |
pmid:25362655 | ||||
pmid:25354898 | ||||
Arrigoni C et al. | Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. | 2014 | Mol. Cancer | pmid:25335447 |
pmid:25333856 | ||||
pmid:25323794 | ||||
pmid:25323324 | ||||
Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
pmid:25316684 | ||||
Cardelli M and Aubin JE | ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. | 2014 | PLoS ONE | pmid:25313644 |
Movérare-Skrtic S et al. | Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. | 2014 | Nat. Med. | pmid:25306233 |
Holt V et al. | Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. | 2014 | PLoS ONE | pmid:25302610 |
Moran CS et al. | Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. | 2014 | Arterioscler. Thromb. Vasc. Biol. | pmid:25301844 |
Schündeln MM et al. | Impairment of bone health in pediatric patients with hemolytic anemia. | 2014 | PLoS ONE | pmid:25299063 |
Nascimento MM et al. | Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. | 2014 | Braz. J. Med. Biol. Res. | pmid:25296363 |
pmid:25292314 | ||||
Kuroyanagi G et al. | Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts. | 2014 | Int J Mol Sci | pmid:25290095 |
Brabnikova-Maresova K et al. | Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. | 2014 | Arthritis Res. Ther. | pmid:25280749 |
pmid:25280574 | ||||
pmid:25274266 | ||||
pmid:25270538 | ||||
Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |
pmid:25268406 |